Subsequently, to explore gene divergence and identify potential biomarkers for late-stage NPCs, we conducted scRNA-seq analysis, which confirmed that SRGN expression was significantly augmented in SDD tissue compared with MDD tissue, especially in late-stage NPCs. This evidence concerns the gene SRGN and major depressive disorder.